Hetero Labs

Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thu, 09/25/14 - 09:25 am
generics
Sovaldi
Gilead Sciences
hepatitis C
Mylan
Strides Arcolab
Cadila
Cipla
Hetero Labs
Ranbaxy
Sequent Scientific
Forest Laboratories, Inc. Announces Settlement Agreement with Hetero Labs Ltd. in BYSTOLIC® Patent Litigation
Business Wire
Sat, 10/27/12 - 12:25 pm
Forrest
Hetero Labs
Bystolic
generics
patents
lawsuits